Homocysteine
Updated: Sep 24, 2020
Author: Georges Elhomsy, MD, ECNU, FACE; Chief Editor: Eric B Staros, MD
Reference Range
Plasma and urine homocysteine tests are indicated in the screening and diagnosis of different types of homocystinuria.
Normal findings: 4-14 μmol/L (Levels may rise with age.)[1]
Interpretation
Plasma and urine homocysteine levels are usually elevated in homocystinuria, an inborn error of metabolism that can result from many enzymatic defects, including the following:
-
Cystathionine β-synthase deficiency
-
Defects in methylcobalamin formation[2]
-
Methylenetetrahydrofolate reductase deficiency
Plasma homocysteine levels are elevated in vitamin B-12 deficiency, vitamin B-6 deficiency and in folic acid deficiency.[3]
Whether elevated plasma and urine homocysteine levels represent a cardiovascular risk factor is debatable.[4]
Plasma homocysteine levels can also increase in association with increading age, hypothyroidism, impaired kidney function, systemic lupus erythematosus, and certain medications, such as nitrous oxide, methotrexate, phenytoin, and carbamazepine.
Collection and Panels
Patient instructions: Fasting is preferred
Collection tube: Lavender-top tube, green-top tube, or gel-barrier tube
Unacceptable conditions: Grossly hemolyzed specimens
Specimen preparation: Plasma (preferred) or serum should be separated within one hour of collection and then transferred to a transport tube.
Storage/transport temperature: Refrigerated
Stability: Room temperature, 1 hour; refrigerated, 1 week; frozen, 3 months
Panels: None
Background
Description
Homocysteine is a sulfur-containing amino acid; in plasma, it undergoes oxidization and transforms to disulfides homocystine and cysteine-homocysteine, the measured plasma level reflects these 3 components.
Homocysteine play an important role in many metabolic pathways, mainly the methionine cycle to the folate cycle (see image below).[5]
simplified picture, showing Homocysteine involvement in different metabolic pathways as well as the role of vitamin B6, B12 and Folate as a co-factor in this pathways.
Caption: Homocysteine involvement in different metabolic pathways, as well as the role of vitamin B-6, vitamin B-12, and folate as cofactors in these pathways.
Indications/Applications
Plasma and urine homocysteine tests are indicated in the screening and diagnosis of different types of homocystinuria.
Considerations
Plasma homocysteine levels are usually severely elevated in homozygous cystathionine-β synthase deficiency and moderately elevated in heterozygous cystathionine-β synthase deficiency. In the other mutations associated with homocystinuria, plasma levels can vary from high to intermediate.
Many epidemiological studies have shown that plasma homocysteine levels are higher in patients with coronary heart disease, stroke, peripheral vascular disease, or thromboembolic disease, but recent meta-analysis showed that lifelong moderate homocysteine elevation has little or no effect on coronary heart disease.[6, 4]
Plasma homocysteine levels can be elevated in vitamin B-12, folate (vitamin B-9), and vitamin B-6 deficiencies.
In most cases, vitamin B-12 deficiency is associated with an elevation in plasma homocysteine and methylmalonic acid levels, whereas folate deficiency is associated with elevated homocysteine levels only.
Author
Georges Elhomsy, MD, ECNU, FACE Assistant Professor of Medicine, University of Kansas School of Medicine-Wichita
Georges Elhomsy, MD, ECNU, FACE is a member of the following medical societies: American Association of Clinical Endocrinologists, American College of Endocrinology, American College of Physicians, Endocrine Society, The Obesity Society
Disclosure: Received income in an amount equal to or greater than $250 from: Corcept and Novo-nordisk .
Chief Editor
Eric B Staros, MD Associate Professor of Pathology, St Louis University School of Medicine; Director of Clinical Laboratories, Director of Cytopathology, Department of Pathology, St Louis University Hospital
Eric B Staros, MD is a member of the following medical societies: American Medical Association, American Society for Clinical Pathology, Association for Molecular Pathology, College of American Pathologists
Disclosure: Nothing to disclose.
Pagana KD, Pagana TJ, Pagana TN. Mosby’s Diagnostic and Laboratory Test Reference. 14th ed. St. Louis, MO: Elsevier; 2019. 513.
Nilsson TK, Böttiger AK, Henríquez P, Majem LS. MTHFR polymorphisms and serum cobalamin affect plasma homocysteine concentrations differentially in females and males. Mol Med Rep. 2014 Aug 28. [QxMD MEDLINE Link].
Pirouzpanah S, Taleban FA, Mehdipour P, Atri M, Foroutan-Ghaznavi M. Plasma Total Homocysteine Level in Association With Folate, Pyridoxine, and Cobalamin Status Among Iranian Primary Breast Cancer Patients. Nutr Cancer. 2014 Aug 26. 1-12. [QxMD MEDLINE Link].
Zhang F, Li X, Dong Q, Wang Y, Zhang H. Risk of Acute Cerebral Infarction and Plasma Asymmetrical Dimethylarginine and Homocysteine Levels: A Clinical Correlation Analysis of Chinese Population. J Stroke Cerebrovasc Dis. 2014 Aug 26. [QxMD MEDLINE Link].
Rezvani I, Rosenblatt DS. Defects in Metabolism of Amino Acids, Methionine. Kliegman, ed. Nelson Textbook of Pediatrics. 19th ed. Philadelphia, PA. Elsevier, Saunders; 2011.; Chap 79.
Clarke R, Bennett DA, Parish S, et Al; MTHFR Studies Collaborative Group. Homocysteine and coronary heart disease: meta-analysis of MTHFR case-control studies, avoiding publication bias. PLoS Med. 2012 Feb;9(2):e1001177. Epub 2012 Feb 21.
Ferri FF, ed. Laboratory Tests and Interpretation of Results. Ferri's Clinical Advisor, 1st ed. Elsevier Mosby; 2012.; Section IV:
Mayo Clinic. Test ID: HCYSP Homocysteine, Total, Plasma. Available at http://www.mayomedicallaboratories.com/test-catalog/Clinical+and+Interpretive/80379. Accessed: April 24, 2012.
Mayo Clinic. Test ID: HCYSU Homocysteine, Total, Urine. Available at http://www.mayomedicallaboratories.com/test-catalog/Clinical+and+Interpretive/80378. Accessed: April 24, 2012.